A ZIKV purified inactivated virus Zika vaccine candidate provided robust protection against the virus in rhesus monkeys in a new preclinical study. Findings support advancing the candidate to human trials.
A ZIKV purified inactivated virus Zika vaccine candidate provided robust protection against the virus in rhesus monkeys in a new preclinical study. Findings support advancing the candidate to human trials.
Share this Article
Recommended